Welcome to Chinese Journal of Clinical Pharmacology and Therapeutics,Today is Chinese

Chinese Journal of Clinical Pharmacology and Therapeutics ›› 2026, Vol. 31 ›› Issue (10): 1297-1309.doi: 10.12092/j.issn.1009-2501.2026.10.001

    Next Articles

Research on the role of STING1 in diabetic atherosclerotic blood vessels and retina

Yi LIU1(), Wenhua YU2(), Yunjian SONG3, Mingfeng JIN1, Xin JIANG1, Zhongqun WANG1,*()   

  1. 1. Department of Cardiology, Affiliated Hospital of Jiangsu University, Zhenjiang 212001, Jiangsu, China
    2. Department of Cardiology, Nantong Hospital of Traditional Chinese Medicine, Nantong 226001, Jiangsu, China
    3. Basic Medical Research Center, Medical School of Nantong University, Nantong 226001, Jiangsu, China
  • Received:2025-10-22 Revised:2026-01-28 Online:2026-10-26 Published:2026-11-11
  • Contact: Zhongqun WANG E-mail:84413029@qq.com;ywh295667@163.com;wangtsmc@126.com

Abstract:

AIM: To investigate the role of stimulator of interferon genes 1 (STING1) in diabetic atherosclerotic vascular and retinal pathologies. METHODS: Using ApoE?/? mice and STING1?/?/ApoE?/? mice as experimental subjects, the diabetic models were established by intraperitoneal injection of streptozotocin (STZ), with random blood glucose levels >16.7 mmol/L after two weeks. These mice were further fed a high-fat diet for 16 weeks to develop diabetic atherosclerosis models. The successfully modeled mice were divided into the ApoE?/? diabetic group (ApoE?/? + high-fat diet + STZ) and STING1?/?/ApoE?/? diabetic group (STING1?/?/ApoE?/? + high-fat diet + STZ). An additional control group (ApoE?/? + high-fat diet) with atherosclerosis was also established. Lipid metabolism indicators and inflammatory factors were measured using Enzyme-Linked Immunosorbent Assay (ELISA). Morphological changes in aortic plaques and retina were observed through Hematoxylin-Eosin (HE) staining, Masson,s Trichrome (Masson) staining, and periodic acid-Schiff (PAS) staining. Western blotting and immunohistochemical staining were performed on plaques and retina to assess STING1 expression. Furthermore, neovasculature formation in arterial plaques and retinal tissues was evaluated using antibodies CD31, CD34, and LYVE-1. RESULTS: Compared with the control group, diabetic mice exhibited elevated levels of blood lipids and inflammation, increased atherosclerotic plaque area, reduced collagen deposition, thickened retina, and increased acellular capillaries. STING1 expression was also significantly upregulated in both plaques and retina. In contrast, STING1 deficiency reduced plaque area and retinal thickness and increased intraplaque collagen content. In addition, knocking out STING1 inhibited neovascularization within plaques and the retina. STING1 expression levels were positively correlated with both aortic plaque area and retinal thickness (P <0.05). CONCLUSION: STING1 expression significantly influenced the progression of diabetic atherosclerotic plaques, pathological changes in retinal tissue, and angiogenesis. This suggests that STING1 may serve as a common molecular bridge for diabetic vascular and retinopathy, providing a potential target for developing novel therapeutic strategies.

Key words: diabetes, atherosclerosis, retinopathy, STING1

CLC Number: